IL17A and breast carcinoma: Although underlying mechanism is still not quite clear, studies showed that genetic polymorphisms of IL17 were associated with the susceptibility to a range of inflammation-related diseases, including rheumatoid arthritis, ulcerative colitis, gastric cancer, and breast cancer [16–19].